Biotech Series A Investors & VC Firms
1596 firms in this list, with a median first check of $500K. 341 of them lead rounds. Generated from verified public data and updated continuously.
Clarendon Fund Managers Ltd.
BelfastPre-Seed–Growth$25K – $3.9M
13 people
Seafund
BengaluruPre-Seed–Series A$300K – $750K
19 people
Dolby Family Ventures
San FranciscoPre-Seed–Series A
21 people
Primo Ventures
MilanPre-Seed–Growth$1.1M
18 people
Innovation Industries
AmsterdamSeed–Late Stage$2.2M – $54M
25 people
Kreos Capital
LondonSeries A–Late Stage
43 people
Unruly Capital
LondonPre-Seed–Series A
3 people
Ysios Capital
BarcelonaSeries A–Late Stage$5.4M – $21.6M
26 people
Golden Ventures
TorontoPre-Seed–Series A$500K – $2.5M
10 people
XMS Capital Partners
ChicagoSeries A
44 people
Artesian
AustraliaPre-Seed–Late Stage
42 people
Artis Ventures
San FranciscoSeed–Late Stage$50K – $25M
7 people
Decheng Capital
Menlo ParkSeed–Growth
16 people
Abingworth
LondonPre-Seed–Late Stage$15M – $30M
39 people
Ahren Innovation Capital
Cambridge, CambridgeshirePre-Seed–Late Stage
30 people
Jumpstart Ventures
ClevelandPre-Seed–Series A$500K – $2M
5 people
Agent Capital
WalthamPre-Seed–Late Stage
22 people
SOSV
New YorkPre-Seed–Series B$30K – $550K
29 people
Mission Biocapital
San FranciscoPre-Seed–Series A$500K
21 people
Fortune Venture Capital
ShenzhenSeed–Late Stage$425K – $73M
11 people
UntroD Capital
TokyoPre-Seed–Growth$772K – $241M
5 people
Avoro Capital Advisors
New YorkSeed–Series A
22 people
Medicxi
LondonPre-Seed–Late Stage
34 people
S32
Palo AltoSeries A–Late Stage
25 people
Related lists
Series A Investors & VC Firms (7875)Series A Investors & VC Firms in United States (3337)SaaS Series A Investors & VC Firms (2667)AI & Machine Learning Series A Investors & VC Firms (2343)Enterprise Software Series A Investors & VC Firms (2324)Fintech Series A Investors & VC Firms (2239)Healthtech Series A Investors & VC Firms (2210)Series A Investors & VC Firms in Global (2163)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)
Data sourced from public filings and firms' own websites — see our methodology.


































































